Safety and Tolerability of Ciclesonide and Formoterol Fumarate Inhaled Once Daily in Patients With Asthma (18 to 75 y) (BY9010/M1-506)
Clinical trial NCT00314509 · COMPLETED
Trial details
- NCT number
- NCT00314509
- Sponsor
- AstraZeneca
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2005-07-01
- Primary completion
- 2006-01-01
- Enrollment
- 240
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.